Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moreau

Showing results (31-40 of 786) with videos related to

Pageof 79
Sort By:
Expert Opinion on Biological Therapy|April 25, 2017
Daratumumab for the treatment of multiple myelomaCyrille Touzeau, Philippe Moreau
Acta Haematologica|July 5, 2014
New data on subcutaneous bortezomibPhilippe Moreau, Cyrille Touzeau
Clinical Lymphoma & Myeloma|October 20, 2005
Evolving role of stem cell transplantation in multiple myelomaJean-Luc Harousseau, Philippe Moreau
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Role of bone marrow transplantation in the disease pathway of myelomaJean-Luc Harousseau, Philippe Moreau
The New England Journal of Medicine|June 19, 2009
Autologous hematopoietic stem-cell transplantation for multiple myelomaJean-Luc Harousseau, Philippe Moreau
Leukemia Research|November 27, 2012
Optimizing therapy for transplant-eligible patients with newly diagnosed multiple myelomaPhilippe Moreau, Sergio A Giralt
Lancet (London, England)|July 15, 2016
Multiple myeloma--translation of trial results into realityPhilippe Moreau, S Vincent Rajkumar
British Journal of Haematology|May 31, 2017
Recent progress in relapsed multiple myeloma therapy: implications for treatment decisionsPhilippe Moreau, Edwin de Wit
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2021
Reply to G. R. Mohyuddin et al and A. Garfall et alPaul G Richardson, Philippe Moreau
Leukemia Research|March 21, 2012
"Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?"Philippe Moreau, S Vincent Rajkumar
Pageof 79

Showing results (31-40 of 786) with videos related to

Sort By:
Pageof 79
Expert Opinion on Biological Therapy|April 25, 2017
Daratumumab for the treatment of multiple myelomaCyrille Touzeau, Philippe Moreau
Acta Haematologica|July 5, 2014
New data on subcutaneous bortezomibPhilippe Moreau, Cyrille Touzeau
Clinical Lymphoma & Myeloma|October 20, 2005
Evolving role of stem cell transplantation in multiple myelomaJean-Luc Harousseau, Philippe Moreau
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Role of bone marrow transplantation in the disease pathway of myelomaJean-Luc Harousseau, Philippe Moreau
The New England Journal of Medicine|June 19, 2009
Autologous hematopoietic stem-cell transplantation for multiple myelomaJean-Luc Harousseau, Philippe Moreau
Leukemia Research|November 27, 2012
Optimizing therapy for transplant-eligible patients with newly diagnosed multiple myelomaPhilippe Moreau, Sergio A Giralt
Lancet (London, England)|July 15, 2016
Multiple myeloma--translation of trial results into realityPhilippe Moreau, S Vincent Rajkumar
British Journal of Haematology|May 31, 2017
Recent progress in relapsed multiple myeloma therapy: implications for treatment decisionsPhilippe Moreau, Edwin de Wit
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2021
Reply to G. R. Mohyuddin et al and A. Garfall et alPaul G Richardson, Philippe Moreau
Leukemia Research|March 21, 2012
"Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?"Philippe Moreau, S Vincent Rajkumar
Pageof 79